This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Korea Institute of Science and Technology, Yonsei University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: Taek Joo Lee: Innovator in Cancer Treatment
Introduction
Taek Joo Lee is a prominent inventor based in Yongin, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and patented compositions. With a total of 2 patents, his work focuses on developing effective agents for preventing and treating cancer.
Latest Patents
Taek Joo Lee's latest patents include compositions for preventing or treating cancer that comprise extracts of var. tozawai (Nakai) T.B. Lee. These compositions are designed to include extracts or fractions thereof as active ingredients. Notably, the var. tozawai (Nakai) T.B. Lee extract has demonstrated excellent anticancer efficacy against various cancers, including diffuse-type gastric cancer. This research indicates that a cancer treatment agent with remarkable effects can be developed using this extract as an active ingredient. Additionally, he has patented compositions for preventing or treating cancer that include Nakai extracts, which also show significant anticancer efficacy against various cancers.
Career Highlights
Throughout his career, Taek Joo Lee has worked with esteemed institutions such as Yonsei University and the Korea Institute of Science and Technology. His research has been pivotal in advancing the understanding and treatment of cancer.
Collaborations
Some of his notable coworkers include Jung Hwa Kang and Wan Hee Lee. Their collaborative efforts have contributed to the success of his research and innovations.
Conclusion
Taek Joo Lee's contributions to cancer treatment through his innovative patents highlight his dedication to improving healthcare. His work continues to inspire advancements in the field of oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile